Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
Alamar Biosciences partners with leading US research universities and organizations to profile approximately 21,000 plasma samples from 10,000 Alzheimer’s Disease and Related Dementias participants using its NULISAseq Neuro 220 panel. This large-scale proteomics initiative aims to accelerate biomarker discovery and validation, creating an open-acce…